Clinical Trial Update: NO During CPB in Neonates to Reduce Risk of AKI [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating inhaled nitric oxide during cardiopulmonary bypass in neonates to lower the risk of acute kidney injury; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Kidney Injury

Drugs mentioned

• Nitric oxide (inhaled) (nitric oxide)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: AKI, CHD - Congenital Heart Disease | Phase 3 | Status: RECRUITING